Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Total 13F shares
-
2,996,559
-
Share change
-
-27,449
-
Total reported value
-
$9,410,646
-
Price per share
-
$3.14
-
Number of holders
-
24
-
Value change
-
-$91,671
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2019
As of 30 Jun 2019,
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,996,559 shares.
The largest 10 holders included
Lagoda Investment Management, L.P., VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, OPPENHEIMER & CO INC, NORTHERN TRUST CORP, CREDIT SUISSE AG/, Bank of New York Mellon Corp, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
24
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.